192 related articles for article (PubMed ID: 27446428)
21. Utility of immunohistochemical investigation of SDHB and molecular genetic analysis of SDH genes in the differential diagnosis of mesenchymal tumors of GIT.
Dubova M; Sedivcova M; Michal M; Kokoskova B; Ryska A; Smid D; Daum O
Histol Histopathol; 2015 Feb; 30(2):223-32. PubMed ID: 25205505
[TBL] [Abstract][Full Text] [Related]
22. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
23. DOG1 for the diagnosis of gastrointestinal stromal tumor (GIST): Comparison between 2 different antibodies.
Lopes LF; West RB; Bacchi LM; van de Rijn M; Bacchi CE
Appl Immunohistochem Mol Morphol; 2010 Jul; 18(4):333-7. PubMed ID: 20571340
[TBL] [Abstract][Full Text] [Related]
24. Expression of DOG1, CD117 and PDGFRA in gastrointestinal stromal tumors and correlations with clinicopathology.
Sui XL; Wang H; Sun XW
Asian Pac J Cancer Prev; 2012; 13(4):1389-93. PubMed ID: 22799337
[TBL] [Abstract][Full Text] [Related]
25. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34.
Sarlomo-Rikala M; Kovatich AJ; Barusevicius A; Miettinen M
Mod Pathol; 1998 Aug; 11(8):728-34. PubMed ID: 9720500
[TBL] [Abstract][Full Text] [Related]
26. Does Immunohistochemistry for Discovered on GIST1 and Minichromosome Maintenance Protein7 Provide Additional Clinicopathological Value in Gastrointestinal Stromal Tumors?
Abd El-Rehim DM; Gayyed MF
World J Oncol; 2015 Jun; 6(3):355-363. PubMed ID: 28983330
[TBL] [Abstract][Full Text] [Related]
27. Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract.
Coco DP; Hirsch MS; Hornick JL
Am J Surg Pathol; 2009 Dec; 33(12):1795-801. PubMed ID: 19950405
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal stromal tumors--value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas.
Miettinen M; Virolainen M; Maarit-Sarlomo-Rikala
Am J Surg Pathol; 1995 Feb; 19(2):207-16. PubMed ID: 7530409
[TBL] [Abstract][Full Text] [Related]
29. Reclassification of gastrointestinal mesenchymal tumors.
Kamoun S; M'sakni I; Mansouri N; Laabidi B; Helali A; Gordah AN; Bougrine F; Bouziani A
Tunis Med; 2015 Dec; 93(12):746-9. PubMed ID: 27249382
[TBL] [Abstract][Full Text] [Related]
30. The utility of discovered on gastrointestinal stromal tumor 1 (DOG1) antibody in surgical pathology-the GIST of it.
Lee CH; Liang CW; Espinosa I
Adv Anat Pathol; 2010 May; 17(3):222-32. PubMed ID: 20418677
[TBL] [Abstract][Full Text] [Related]
31. Esophageal mesenchymal tumors: endoscopy, pathology and immunohistochemistry.
Zhu X; Zhang XQ; Li BM; Xu P; Zhang KH; Chen J
World J Gastroenterol; 2007 Feb; 13(5):768-73. PubMed ID: 17278201
[TBL] [Abstract][Full Text] [Related]
32. Contribution of DOG1 expression to the diagnosis of gastrointestinal stromal tumors.
Kara T; Serinsoz E; Arpaci RB; Gubur O; Orekici G; Ata A; Colak T; Arican A
Pathol Res Pract; 2013 Jul; 209(7):413-7. PubMed ID: 23722018
[TBL] [Abstract][Full Text] [Related]
33. [The role of the DOG1 antibody in the diagnosis of gastrointestinal stromal tumours - GIST].
Gutierrez MR; Dorronsoro ML; Marco AM; Pérez IR; Villegas IA; Virseda JM
An Sist Sanit Navar; 2011; 34(2):245-51. PubMed ID: 21904406
[TBL] [Abstract][Full Text] [Related]
34. Expression of angiopoietin-1, 2 and 4 and Tie-1 and 2 in gastrointestinal stromal tumor, leiomyoma and schwannoma.
Nakayama T; Inaba M; Naito S; Mihara Y; Miura S; Taba M; Yoshizaki A; Wen CY; Sekine I
World J Gastroenterol; 2007 Sep; 13(33):4473-9. PubMed ID: 17724803
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases.
Miettinen M; Monihan JM; Sarlomo-Rikala M; Kovatich AJ; Carr NJ; Emory TS; Sobin LH
Am J Surg Pathol; 1999 Sep; 23(9):1109-18. PubMed ID: 10478672
[TBL] [Abstract][Full Text] [Related]
36. Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations.
Rizzo FM; Palmirotta R; Marzullo A; Resta N; Cives M; Tucci M; Silvestris F
BMC Cancer; 2016 Feb; 16():87. PubMed ID: 26867653
[TBL] [Abstract][Full Text] [Related]
37. [Gastrointestinal stromal tumors: definition, histological, immunohistochemical, and molecular features, and diagnostic strategy].
Coindre JM; Emile JF; Monges G; Ranchère-Vince D; Scoazec JY
Ann Pathol; 2005 Oct; 25(5):358-85; quiz 357. PubMed ID: 16498290
[TBL] [Abstract][Full Text] [Related]
38. Endosonographic evaluation of c-kit-positive gastrointestinal stromal tumor.
Okai T; Minamoto T; Ohtsubo K; Minato H; Kurumaya H; Oda Y; Mai M; Sawabu N
Abdom Imaging; 2003; 28(3):301-7. PubMed ID: 12719898
[TBL] [Abstract][Full Text] [Related]
39. Clinical Diagnosis of Gastrointestinal Stromal Tumor (GIST): From the Molecular Genetic Point of View.
Wu CE; Tzen CY; Wang SY; Yeh CN
Cancers (Basel); 2019 May; 11(5):. PubMed ID: 31100836
[TBL] [Abstract][Full Text] [Related]
40. Expression of vascular endothelial growth factor and its receptors VEGFR-1 and 2 in gastrointestinal stromal tumors, leiomyomas and schwannomas.
Nakayama T; Cho YC; Mine Y; Yoshizaki A; Naito S; Wen CY; Sekine I
World J Gastroenterol; 2006 Oct; 12(38):6182-7. PubMed ID: 17036392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
